Company / Gross Profit per Share
ENDONOVO THERAPEUTICS, INC. Gross Profit per Share History
FY2014-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.00
FY2022
5-year range
$0.00 / $0.50
FY2018-FY2022
Trend
-29.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share has declined for 3 consecutive years, from $0.50 in FY2019 to $0.00 in FY2022.
Based on SEC 10-K filings.
0.00 in FY2022 with a 3-year CAGR of -85.0%.
Declined from $0.08 to $0.00 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -85.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ENDONOVO THERAPEUTICS, INC.'s gross profit per share has declined for 3 consecutive years.
- In FY2022, gross profit per share decreased 29.0% year-over-year.
- Peak gross profit per share was recorded in FY2019.
- Lowest gross profit per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.00 | -29.0% |
| FY2021 | $0.00 | -97.2% |
| FY2020 | $0.08 | -83.2% |
| FY2019 | $0.50 | +226526.4% |
| FY2018 | $0.00 | - |
| FY2016 | - | - |
| FY2015 | $0.00 | -99.8% |
| FY2014 | $0.01 | - |
| FY2011 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 29, 2026